Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine

QU Yi-lun; DONG Zhe-yi; CHENG Hai-mei; LIU Qian; WANG Qian; YANG Hong-tao; MAO Yong-hui; LI Ji-jun; LIU Hong-fang; GENG Yan-qiu; HUANG Wen; LIU Wen-hu; XIE Hui-di; PENG Fei; LI Shuang; JIANG Shuang-shuang; LI Wei-zhen; DUAN Shu-wei; FENG Zhe; ZHANG Wei-guang; LIU Yu-ning; TIAN Jin-zhou; CHEN Xiang-mei

doi:10.1007/s11655-022-3520-0

Your Location：

Home >

Browse articles >

Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine

Original Article | Updated：2023-04-05

- Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine
- Chinese Journal of Integrative Medicine Vol. 29, Issue 4, Pages: 308-315(2023)
- Affiliations：
  
  1.Department of Nephrology, First Medical Center of Chinese People's Liberation Army General Hospital, Nephrology Institute of the Chinese People's Liberation Army, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Disease Research, Beijing (100853), China
  2.Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine; Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China; Institute of Chinese Medicine, Guangdong Pharmaceutical University; Guangdong Traditional Chinese Medicine Key Laboratory for Metabolic Diseases, Guangzhou(510006), China
  3.Department of Nephrology, The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin (300193), China
  4.Department of Nephrology, Beijing Hospital, Beijing (100730), China
  5.Department of Nephrology, The Forth Medical Center of People's Liberation Army General Hospital, Beijing (100039), China
  6.Department of Endocrinology, Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine, Beijing (100700), China
  7.Department of Nephrology, The Third Medical Center of PLA General Hospital, Beijing(100039), China
  8.Department of Nephrology, Beijing Tongren Hospital, Capital Medical University, Beijing (100730), China
  9.Department of Nephrology, Beijing Friendship Hospital, Faculty of Kidney Diseases, Capital Medical University, Beijing (100050), China
  10.Department of Nephrology, Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine, Beijing(100700), China
  11.Three Departments of Encephalopathy, Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing (100700), China
- Author bio：
  
  Prof. CHEN Xiang-mei, E-mail: xmchen301@126.com
- Funds：
- DOI：10.1007/s11655-022-3520-0
  CLC：
- Published：2023-04，
  
  Published Online：09 June 2022，
  
  Accepted：21 June 2021
Scan for full text
QU Yi-lun, DONG Zhe-yi, CHENG Hai-mei, et al. Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine. [J]. Chinese Journal of Integrative Medicine 29(4):308-315(2023)
DOI：

QU Yi-lun, DONG Zhe-yi, CHENG Hai-mei, et al. Evaluation of Renal Impairment in Patients with Diabetic Kidney Disease by Integrated Chinese and Western Medicine. [J]. Chinese Journal of Integrative Medicine 29(4):308-315(2023) DOI： 10.1007/s11655-022-3520-0.

摘要

目的:

从中西医结合的角度研究糖尿病肾病(DKD)患者肾功能损害的相关因素.

方法:

纳入2017年10月至2019年7月于中国8家医院就诊的DKD患者共492例. 根据改善全球肾脏病预后组织(KDIGO)指南将患者分为CKD1-3期组及CKD4-5期组. 收集患者的临床资料

通过Logistic回归研究2型糖尿病患者不同CKD分期的相关因素.

结果:

人口统计学资料结果显示

男性是 DKD 患者 CKD 分期增加的相关因素(OR=3.100

=0.002). 从临床特征分析

患者糖尿病病程

60个月(OR=3.562

=0.010)、贫血(OR=4.176

0.001)、高尿酸血症(OR=3.352

0.001)、大量白蛋白尿(OR=4.058

=0.002)、动脉粥样硬化(OR=2.153

=0.007)和血虚证(OR=1.945

=0.020)是DKD患者CKD分期增加的相关因素.

结论:

男性、糖尿病病程>60个月、贫血、高尿酸血症、大量蛋白尿、动脉粥样硬化、血虚证可能提示DKD患者肾功能损害程度较重(试验注册号: NCT03865914).

Abstract

Objective:

To investigate the factors related to renal impairment in patients with diabetic kidney disease (DKD) from the perspective of integrated Chinese and Western medicine.

Methods:

Totally 492 patients with DKD in 8 Chinese hospitals from October 2017 to July 2019 were included. According to Kidney Disease Improving Global Outcomes (KDIGO) staging guidelines

patients were divided into a chronic kidney disease (CKD) 1–3 group and a CKD 4–5 group. Clinical data were collected

and logistic regression was used to analyze the factors related to different CKD stages in DKD patients.

Results:

Demographically

male was a factor related to increased CKD staging in patients with DKD (OR=3.100

=0.002). In clinical characteristics

course of diabetes

60 months (OR=3.562

=0.010)

anemia (OR=4.176

0.001)

hyperuricemia (OR=3.352

0.001)

massive albuminuria (OR=4.058

=0.002)

atherosclerosis (OR=2.153

=0.007) and blood deficiency syndrome (OR=1.945

=0.020) were factors related to increased CKD staging in patients with DKD.

Conclusion:

Male

course of diabetes >60 months

anemia

hyperuricemia

massive proteinuria

atherosclerosis

and blood deficiency syndrome might indicate more severe degree of renal function damage in patients with DKD. (Registration No. NCT03865914)

关键词

Keywords

diabetic kidney diseaseintegrated Chinese and Western medicineChinese medicine syndrome

references

Afkarian M, Sachs MC, Kestenbaum B, Hirsch IB, Tuttle KR, Himmelfarb J, et al. Kidney disease and increased mortality risk in type 2 diabetes. J Am Soc Nephrol 2013;24:302-308.

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018;138:271-281.

Cao XX, Xu CJ, Hou YB, Wang Y, Fan N, Xu FS, et al. The epidemic trend and prediction of chronic diseases with high incidence in China from 1990 to 2025. Chin J Prev Contrl Chron Dis (Chin) 2020;28:14-19.

Low S, Lim SC, Zhang X, Zhou S, Yeoh LY, Liu YL, et al. Development and validation of a predictive model for chronic kidney disease progression in type 2 diabetes mellitus based on a 13-year study in Singapore. Diabetes Res Clin Pract 2017;123:49-54.

Wang Y, Zhou JW, Wang Z, Yang YX, Wang YX. Advances in the treatment of diabetic nephropathy with traditional Chinese and Western medicine. Chin Gener Med (Chin) 2022;25:1411-1417.

Expert Consensus on the Prevention and Treatment of Diabetic nephropathy (2014 edition). Chin J Diabetes (Chin) 2014;6:792-801.

Lv RH, Zhang FR, Gao YB. Diabetes Professional Committee of the Society of Internal Medicine of the Chinese Society of traditional Chinese Medicine. Criteria for TCM staging, syndrome differentiation and curative effect evaluation of "Wasting–thirst" (diabetes mellitus). Chin J Med 1993;8:54-56.

Zheng XY, ed. Guiding Principles for Clinical Research of New Traditional Chinese Medicines. Beijing: China Medical Science and Technology Press; 2002:233-237.

Tong XL. Chinese Society of traditional Chinese medicine, Guidelines for Traditional Chinese Medicine Prevention and Treatment of Diabetes. Chin Med Modern Dist Edu (Chin)2011;9:151-153.

Stevens PE, Levin A. Evaluation, and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013;158:825-830.

Liu XL, Liu BL. Discussion on the etiology, symptoms, treatment principles and treatment of blood deficiency syndrome based on the ancient literature of traditional Chinese medicine. Beijing J Tradit Chin Med (Chin) 2020;39:262-265.

Wang Y, Liu XM, Lin L. Stages, types, and treatment principles of diabetic nephropathy. Liaoning J Tradit Chin Med (Chin)1999;12:549-550.

Liu MY, Xie YS, Dong ZY, Zhang XG, Sun XF, Zhang D, et al. The role of hemoglobin in differentiating diabetic nephropathy from non-diabetic renal disease. Chin J Kidney Dis Invest(Electr, Chin) 2018;7:271-276.

Lou QL, Ouyang XJ, Gu LB, Mo YZ, Ma R, Nan J, et al. Chronic kidney disease and associated cardiovascular risk factors in Chinese with type 2 diabetes. Diabetes Metab J 2012;36:433-442.

Koye DN, Magliano DJ, Reid CM, Jepson C, Feldman HI, Herman WH, et al. Risk of progression of nonalbuminuric CKD to end-stage kidney disease in people with diabetes: the CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis 2018;72:653-661.

Viazzi F, Greco E, Ceriello A, Fioretto P, Giorda C, Guida P, et al. Apparent treatment resistant hypertension, blood pressure control and the progression of chronic kidney disease in patients with type 2 diabetes. Kidney Blood Press Res 2018;43:422-438.

Carrero JJ, Grams ME, Sang Y, Ärnlöv J, Gasparini A, Matsushita K, et al. Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality. Kidney Int 2017;91:244-251.

Mallat SG, Al Kattar S, Tanios BY, Jurjus A. Hyperuricemia, hypertension, and chronic kidney disease: an emerging association. Curr Hypertens Rep 2016;18:74.

De Pergola G, Cortese F, Termine G, Meliota G, Carbonara R, Masiello M, et al. Uric acid, metabolic syndrome, and atherosclerosis: the chicken or the egg, which comes first? Endocr Metab Immune Disord Drug Targets 2018;18:251-259.

Kohagura K, Kochi M, Miyagi T, Kinjyo T, Maehara Y, Nagahama K, et al. An association between uric acid levels and renal arteriolopathy in chronic kidney disease: a biopsy-based study. Hypertens Res 2013;36:43-49.

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Potential Medicinal Value of Rhein for Diabetic Kidney Disease

Correlation between Characteristics of Coronary Plaque and Chinese Medicine Syndromes of Coronary Heart Disease: A Cross-Sectional Study Analysed by Intravascular Ultrasound

DNA Methylation and Transcription of HLA-F and Serum Cytokines Relate to Chinese Medicine Syndrome Classification in Patients with Chronic Hepatitis B

Improvement and Application of Acute Blood Stasis Rat Model Aligned with the 3Rs (Reduction, Refinement and Replacement) of Humane Animal Experimentation

Observational Study of Chinese Medicine Syndrome Distribution in Patients with Acute Myocardial Infarction and Its Impact on Prognosis

Related Author

No data

Related Institution

Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine

The Second Clinical College of Guangzhou University of Chinese Medicine

Postdoctoral Station of Fujian University of Chinese Medicine

Department of Cardiology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine

Research Center for Traditional Chinese Medicine Complexity System, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰